Status of percutaneous coronary intervention and coronary artery bypass

European Journal of Cardio-thoracic Surgery

Volumn 30, Issue 3, 2006, Pages 419-424

  Barner, Hendrick B ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Coronary artery bypass; Coronary artery disease; Coronary stenting; Percutaneous coronary intervention

Indexed keywords

CLOPIDOGREL; PACLITAXEL; RAPAMYCIN;

ANGINA PECTORIS; ANGIOCARDIOGRAPHY; ARTERY INTIMA PROLIFERATION; CLINICAL TRIAL; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DISEASE ASSOCIATION; DRUG ELUTING STENT; HEART MUSCLE REVASCULARIZATION; HUMAN; INTERMETHOD COMPARISON; LEFT ANTERIOR DESCENDING CORONARY ARTERY; META ANALYSIS; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; RESTENOSIS; REVIEW; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; RISK FACTOR; SURVIVAL; SYSTEMATIC REVIEW; THROMBOSIS; TREATMENT OUTCOME;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ARTERIOSCLEROSIS; CORONARY ARTERY BYPASS; CORONARY VESSELS; HUMANS; MYOCARDIAL REVASCULARIZATION; PROSTHESIS IMPLANTATION; STENTS;

EID: 33746916114     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcts.2006.05.027     Document Type: Review

References (74)

1. Loop F.D. Coronary artery surgery: the end of the beginning. Eur J Cardiothoracic Surg 14 (1998) 554-571
2. The Veterans Administration Coronary Artery Bypass Surgery Cooperative Study Group. Eleven-year survival in the veterans administration randomized trial of coronary artery bypass for stable angina. N Engl J Med 311 (1984) 1333-1339
3. Varnauskas E. Twelve-year follow-up of survival in the randomized European Surgery Study. N Engl J Med 319 (1988) 332-337
4. Rogers W.J., Coggin C.J., Gersh B.J., Fisher L.D., Myers W.O., Oberman A., and The Coronary Artery Surgery Study (CASS). Ten-year follow-up of quality of life in patients randomized to receive medical therapy or coronary artery bypass graft surgery. Circulation 82 (1990) 1647-1658
5. Yusuf S., Zucker D., Peduzzi P., Fisher L.D., Takaro T., Kennedy J.W., Davis K., Killip T., Passamani E., Norris R., Morris C., Mathur V., Varnauskas E., and Chalmers T.C. Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomized trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration. Lancet 344 (1994) 563-570
6. Gruentzig A.R., Senning A., and Siegenthaler W.E. Nonoperative dilatation of coronary-artery stenosis: percutaneous transluminal coronary angioplasty. N Engl J Med 301 (1979) 61-68
7. Hoffman S.N., Tenbrook J.A., Wolf M.P., Pauker S.G., Salem D.N., and Wong J.B. A meta-analysis of randomized controlled trials comparing coronary artery bypass graft with percutaneous transluminal coronary angioplasty: one- to eight-year outcomes. J Am Coll Cardiol 41 (2003) 1293-1304
8. Bucher H.C., Hengstler P., Schindler C., and Guyatt G.H. Percutaneous transluminal coronary angioplasty versus medical treatment for non-acute coronary heart disease: meta-analysis of randomized trials. BMJ 321 (2000) 73-77
9. Henderson R.A., Pocock S.J., Clayton T.C., Knight R., Fox K.A.A., Julian D.G., and Chamberlain D.A. Seven-year outcome in the RITA-2 trial: coronary angioplasty versus medical therapy. J Am Coll Cardiol 42 (2003) 1161-1170
10. Mercado N., Wijns W., Serruys P.W., Sigwart U., Flather M.D., Stables R.H., O'Neill W., Rodriquez H., Lerms P.A., Hueb W.A., Gersh B.J., Booth J., and Boersma E. One-year outcomes of coronary artery bypass graft surgery versus percutaneous coronary intervention with multiple stenting for multisystem disease: a meta-analysis of individual patient data from randomized clinical trials. J Thorac Cardiovasc Surg 130 (2005) 512-519
11. Hannan E., Racz M.J., Walford G., Jones R.H., Ryan T.J., Benett E., Culliford A.T., Isom O.W., Gold J.P., and Rose E.A. Long-term outcomes of coronary-artery bypass grafting versus stent implantation. New Engl J Med 352 (2005) 2174-2183
12. van Domburg R.T., Takkenberg J.J.M., Noordzij L.J., Saia F., van Herwerden L.A., Serruys P.W.J.C., and Bogers A.J.J.C. Late outcome after stenting or coronary artery bypass surgery for the treatment of multivessel disease: a single-center matched-propensity controlled cohort study. Ann Thorac Surg 79 (2005) 1563-1569
13. Brener S.J., Lytle B.W., Casserly I.P., Schneider J.P., Topol E.J., and Lauer M.S. Propensity analysis of long-term survival after surgical or percutaneous revascularization in patients with multivessel coronary artery disease and high-risk features. Circulation 109 (2004) 2290-2295
14. Hueb W., Soares P.R., Gersh B.J., Cesar L.A.M., Luz P.L., Puig L.B., Martinez E.M., Oliverira S.A., and Ramires J.A.F. The medicine, angioplasty, or surgery study (MASS-II): a randomized, controlled clinical trial of three therapeutic strategies for multivessel coronary artery disease. J Am Coll Cardiol 43 (2004) 1743-1751
15. Smith PK, Califf RM, Tuttle R, Shaw L, Lee KL, Delong E, Lilly R, Sketch M Jr, Peterson E, Jones R. Selection of surgical or percutaneous coronary intervention provides longevity benefit that varies with the severity of coronary disease. Ann Thor Surg; in press.
16. Babapulle M.N., Joseph L., Belisle P., Brophy J.M., and Eisenberg M.J. A hierarchical Bayesian meta-analysis of randomized clinical trials of drug-eluting stents. Lancet 364 (2004) 583-591
17. Lemos P.A., Hoye A., Goedhart D., Arampatzis C.A., Saia F., van der Giessen W.J., McFadden E., Sianos G., Smits P.C., Hofma S.H., de Feyter P.J., van Domberg R.T., and Serruys P.W. Clinical, angiographic, and procedural predictors of angiographic restenosis after sirolimus-eluting stent implantation in complex patients: an evaluation from the rampamycin-eluting stent evaluation at Rotterdam Cardiology Hospital (RESEARCH) study. Circulation 109 (2004) 1366-1370
18. Lansky A.J., Costa R.A., Mintz G.S., Tsuchiya Y., Midei M., Cox D.A., O'Shaunghessy C., Applegate R.A., Cannon L.A., Mooney M., Farah A., Tannenbaum M.A., Yakubon S., Kereiakes D.J., Wong S.C., Kaplan B., Cristea E., Stone G.W., Leon M.B., Knopf W.D., O'Neill W.O., and for the DELIVER Clinical Trial Investigators. Non-polymer-based paclitaxel-coated coronary stents for the treatment of patients with de novo coronary lesions: angiographic follow-up of the DELIVER clinical trial. Circulation 109 (2004) 1948-1954
19. Tanabe K., Hove A.A., Lemos P.A., Aoke J., Arampatzis C.A., Saia F., Lee C., Degertekin M., Hofma S.H., Sianos G., McFadden E., Smits P.C., van der Geissen W.J., de Feyter P., van Domburg R.T., and Serruys P.W. Restenosis rates following bifurcation stenting with sirolimus-eluting stents for de novo narrowings. Am J Cardiol 91 (2004) 115-118
20. Moreno R., Fernandez C., Hernandez R., Alfonso F., Angiolillo D.J., Sabate M., Escaned J., Banuelos C., Fernandez-Ortiz A., and Macaya C. Drug-eluting stent thrombosis: results from a pooled analysis including ten randomized studies. J Am Coll Cardiol 45 (2005) 954-959
21. Ong A.T.L., McFadden E.P., Regar E., deJaegere P.P.T., van Domberg R.T., and Surreys P.W. Late angiographic stent thrombosis (LAST) events with drug-eluting stents. J Am Coll Cardiol 45 (2005) 2088-2092
22. Cutlip D.E., Chabra A.G., Baim D.S., Cahuhan M.S., Marulkar S., Massaro J., Bakhai A., Cohen D.J., Kuntz R.E., and Kalon K.L.H. Beyond restenosis: five-year clinical outcomes from second-generation coronary stent trials. Circulation 110 (2004) 1226-1230
23. Herz T., Moshkovitz Y., Loberman D., Uretzky G., Braunstein R., Hendler A., Zivi E., Ben-Gal Y., and Mohr R. Drug-eluting stents versus bilateral internal thoracic grafting for multi-vessel coronary disease. Ann Thorac Surg 80 (2005) 2086-2090
24. The BARI Investigators. Seven-year outcome in bypass angioplasty revascularization investigation (BARI) by treatment and diabetic status. J Am Coll Cardiol 35 (2000) 1122-1129
25. King III S.B., Rosinski A.S., Guyton R.A., Lembo N.J., Weintraub W.S., and for the Emory Angioplasty vs Surgery Trial (EAST) Investigators. Eight-year mortality in the Emory angioplasty versus surgery trial (EAST). J Am Coll Cardiol 35 (2000) 1116-1121
26. Niles N.W., McGrath P.D., Malenka E., Quinton H., Wennberg D., Shubrooks S.J., Tryzelar J.F., Clough R., Hearne M.J., Hernandez Jr. F., Watkins M.W., and O'Connor G.T. Survival of patients after surgical or percutaneous coronary revascularization: results of a large regional prospective study. J Am Coll Cardiol 27 (2001) 1008-1015
27. Abizald A., Costa M.A., Centemero M., Abizaio A.S., Legrand J.M., Limet R.V., Schuler G., Mohr F.W., Lindeboom W., Sousa A.G.M.R., Sousa J.E., van Hout B., Hugenholtz P.G., Unger F., Serruys P.W., and on Behalf of the ARTS Investigators. Clinical and economic impact of diabetes mellitus on percutaneous and surgical treatment of multivessel coronary disease patients: insights from the arterial revascularization therapy study (ARTS) trial. Circulation 104 (2001) 533-538
28. Detre K.M., Lombardo M.S., and Brooks M.M. The effect of previous coronary artery bypass surgery on the prognosis of patients with diabetes who have acute myocardial infarction. N Eng J Med 342 (2000) 989-997
29. Mousa I., Leon M.B., Baim D.S., O'Neill W.W., Popma J.J., Buchbinder M., Midwall J., Simonton C.A., Keim E., Wang P., Kuntz R.E., and Moses J.W. Impact of sirolimus-eluting stents on outcome in diabetic patients: a SIRIUS (SIRolImUS-coated Bx velocity balloon-expandable stent in the treatment of patients with de novo coronary artery lesions) sub-study. Circulation 109 (2004) 2293-2298
30. Stone G.W., Ellis S.G., Cox D.A., Hermiller J., O'Shaughnessy C., Mann J.T., Turco M., Caputo R., Bergin P., Greenberg J., Popma J.J., Russell M.E., and for the TAXUS-IV Investigators. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Eng J Med 350 (2004) 221-231
31. Finn A.V., Palacios I.F., Kastrati A., and Gold H.K. Drug-eluting stents for diabetes medicine: a rush to judgment?. J Am Coll Cardiol 45 (2005) 479-483
32. Katritsis D.G., Karvouni E., and Ioannidis J.P. Meta-analysis comparing drug-eluting stents and bare-metal stents. Am J Cardiol 95 (2005) 640-643
33. King III S.B. Is surgery preferred for the diabetic with multivessel disease? Surgery is preferred for the diabetic with multivessel disease. Circulation 112 (2005) 1500-1507
34. van den Brand M.J.B.M., Rensing B.J.W.N., Morel M.M., Foley D.P., de Valk V., Breeman A., Suryapranata H., Haalebos M.M.P., Wlijns W., Wellens Balcon R., Magee P., Ribeiro E., Buffolo E., Unger F., and Serruys P.W. The effect of completeness of revascularization on event-free survival at one year in the ARTS trial. J Am Coll Cardiol 39 (2002) 559-564
35. Whitlow P.L., Dimas A.P., Bashore T.M., Califf R.M., Bourassa M.G., Chaitman B.R., Rosen A.D., Kip K.E., Stadius M.L., and Alderman E.L. Relationship of extent of revascularization with angina at one year in the bypass angioplasty revascularization investigation (BARI). J Am Coll Cardiol 34 (1999) 1750-1759
36. Kurbaan A.S., Bowler T.J., Iisley C.D., and Rickards A.F. Impact of postangioplasty restenosis on comparisons of outcome between angioplasty and bypass grafting. Coronary angioplasty versus bypass revascularization investigation (CABRI) investigators. Am J Cardiol 82 (1998) 272-276
37. Vander Salm T.J., Kip K.E., Jones R.H., Schaff H.V., Shemin R.J., Aldea G.S., and Detre K.M. What constitutes optimal surgical revascularization? Answers from the bypass angioplasty revascularization investigation (BARI). J Am Coll Cardiol 39 (2002) 565-572
38. Shah P.J., Durairaj M., Gordon I., Fuller J., Rosalion A., Seevanayagam S., Tatoulis J., and Buxton B.F. Factors affecting patency of internal thoracic artery graft: clinical and angiographic study in 1434 symptomatic patients operated between 1982 and 2002. Eur J Cardiothorac Surg 26 (2004) 118-124
39. Diegler A., Thiele H., Falk V., Hambrecht R., Spyrantic N., Sick P., Diederich K.W., Mohr F.W., and Schuler G. Comparison of stenting with minimally invasive bypass surgery for stenosis of the left anterior descending coronary artery. N Eng J Med 347 (2002) 561-566
40. Drenth D.J., Veeger N.J.G.M., Winter J.B., Grandjean J.G., Mariani M.A., van Boven A.J., and Boonstra P.W. A prospective randomized trial comparing stenting with off-pump coronary surgery for high-grade stenosis in the proximal left anterior descending coronary artery: three-year follow-up. J Am Coll Cardiol 40 (2002) 1955-1960
41. Sawhney N., Moses J.W., Leon M.B., Kuntz R.E., Popma J.J., Bachinski W., Bass T., Demaio S., Fry E., Holmes Jr. D.R., and Teirstein P.S. Treatment of left anterior descending coronary artery disease with sirolimus-eluting stents. Circulation 110 (2004) 374-379
42. Kappetein A.P., Dawkins K.D., Mohr F.W., Morice M.C., Mack M.J., Russell M.E., Pomar J., and Serruys P.W.J.C. Current percutaneous coronary intervention and coronary artery bypass grafting practices for three-vessel and left main coronary artery disease. Insights from the SYNTAX run-in phase. Eur J Cardiothorac Surg 29 (2006) 486-491
43. Park S.-J., Kim Y.-H., Lee B.-K., Lee S.-W., Hong M.-K., Kim J.-J., Mintz G.S., and Park S.-W. Sirolimus-eluting stent implantation for unprotected left main coronary stenosis: comparison with bare metal stent implantation. J Am Coll Cardiol 45 (2005) 351-356
44. Brophy J.M., Belisle P., and Joseph L. Evidence for use of coronary stents: a hierarchical Bayesian meta-analysis. Ann Intern Med 138 (2003) 777-786
45. King III S.B. Why have stents replaced balloons? Underwhelming evidence. Ann Intern Med 138 (2003) 842-843
46. King III S.B. Dilate of defer? View of a skeptic. J Am Coll Cardio 42 (2003) 1171-1172
47. Califf R.M. Stenting or surgery. An opportunity to do it right. J Am Coll Cardiol 46 (2005) 589-590
48. Boden W.E. Surgery, angioplasty or medical therapy for symptomatic multivessel coronary artery disease: is there an indisputable "winning strategy" from evidenced-based clinical trials?. J Am Coll Cardiol 43 (2004) 1752-1754
49. Gersh B.S., and Frye R.L. Methods of coronary revascularization-things may not be as they seem. N Eng J Med 352 (2005) 2235-2237
50. Opie L.H., Commerford P.J., and Gersh B.J. Controversies in cardiology. 1. Controversies in stable coronary artery disease. Lancet 367 (2006) 69-78
51. Taggart D.P. Current controversies. Surgery is the best intervention for severe coronary artery disease. BMJ 330 (2005) 785-786
52. The SoS Investigators. Coronary artery bypass surgery versus percutaneous coronary intervention with stent implantation. Lancet 360 (2002) 965-970
53. Detre K.M., Rosen A.D., Bost J.E., Cooper M.E., Sutton-Tyrrell K., Holubkov R., Shemin R.J., and Frye R.L. Contemporary practice of coronary revascularization in U.S. hospitals and hospitals participating in the Bypass Angioplasty Revascularization Investigation (BARI). J Am Coll Cardiol 28 (1996) 609-615
54. Buxton B.F., Komeda M., Fuller J.A., and Gordon I. Bilateral internal thoracic artery grafting may improve outcome of coronary artery surgery: risk-adjusted survival. Circulation 98 Suppl II (1998) II-1-II-6
55. Lytle B.W., Blackstone E.H., Sabik J.F., Houghtaling P., Loop F.D., and Cosgrove D.M. The effect of bilateral internal thoracic artery grafting on survival during 20 postoperative years. Ann Thor Surg (2004) 2005-2014
56. Taggart D.P., D'Amico R., and Altman D.G. Effect of arterial revascularization on survival: a systematic review of studies comparing bilateral and single internal mammary arteries. Lancet 358 (2001) 879-885
57. Buxton B.F., Ruengskulrach P., Fuller J., Rosalion A., Reid C.M., and Tatoulis J. The right internal thoracic artery graft: benefits of grafting the left coronary system and native vessels with a high grade stenosis. Eur J Cardiothorac Surg 18 (2000) 255-261
58. Wilson J.M. Stents or surgery: the case for stents. Texas Heart Inst J 32 (2005) 331-338
59. Barner H.B., Standeven J.W., and Reese J. Twelve year experience with internal mammary artery for coronary bypass. J Thorac Cardiovasc Surg 90 (1985) 668-675
60. Dion R., Glineur D., Derouck D., Verhelst R., Noirhomme P., El Khoury G., Degrave E., and Hanet C. Long-term clinical and angiographic follow-up of sequential mammary grafting. Eur J Cardiothorac Surg 17 (2000) 407-414
61. Barner H.B., Sundt III T.M., Bailey M., and Zang Y. Mid-term results of complete arterial revascularization in more than 1000 patients using an internal thoracic artery/radial artery T-graft. Ann Surg 234 (2001) 447-453
62. Tector A.J., McDonald M.L., Kress D.C., Downey F.X., and Schmahl T.M. Purely internal thoracic artery grafts: outcomes. Ann Thorac Surg 72 (2001) 450-455
63. Wendler O., Hennen B., Markwirth T., Konig J., Tscholl D., Huang Q., Shahangi E., and Schafers H.-J. T-grafts with bilateral ITA versus left internal thoracic artery and radial artery: flow dynamics in the internal thoracic artery mainstem. J Thorac Cardiovasc Surg 118 (1999) 841-848
64. Royse A.G., Royse C.F., Groves K.L., Bus B., and Yu G. Blood flow in composite arterial grafts and effect of native coronary flow. Ann Thorac Surg 68 (1999) 1619-1622
65. Affleck D.G., Barner H.B., Bailey M.S., Perry L.A., Maniar H., Prasad S.M., and Damiano Jr. R.J. Flow dynamics of the internal thoracic and radial artery T-graft. Ann Thorac Surg 78 (2004) 1290-1294
66. Bical O.M., Khoury W., Fromes Y., Fischer M., Uva M.S., Boccara G., and Deleuze P.H. Routine use of bilateral skeletonized internal thoracic artery grafts in middle aged diabetic patients. Ann Thorac Surg 78 (2004) 2050-2053
67. Suma H., Isomura T., Hori T., and Sato T. Late angiographic result of using the right gastroepiploic artery as a graft. J Thorac Cardiovasc Surg 120 (2000) 496-498
68. Calafiore A.M., Di Mauro M., D'Alessandro S., Teodori G., Vitolla G., Contini M., Iaco A.L., and Spira G. Revascularization of the lateral wall: long term angiographic and clinical results of radial artery versus right internal thoracic artery grafting. J Thorac Cardiovasc Surg 123 (2002) 225-231
69. Posatti G., Gaudino M., Prati F., Alessandrini F., Trani C., Glieca F., Mazzari M.A., Luciani N., and Schiavoni G. Long-term results of the radial artery used for myocardial revascularization. Circulation 108 (2003) 1350-1354
70. Wendler O., Hennen B., Demertzis S., Markwirth T., Tscholl D., Lausberg H., Huang Q., Dubener L.F., Langer F., and Schafers H.-J. Complete arterial revascularization in multivessel coronary artery disease with 2 conduits (skeletonized grafts and T grafts). Circulation 102 Suppl III (2000) III-79-III-83
71. Tatoulis J., Royse A.G., Buxton B.F., Fuller J.A., Skillington P.D., Goldblatt J.C., Brown R.P., and Rowland M.A. The radial artery in coronary surgery: a 5-year experience - clinical and angiographic results. Ann Thorac Surg 73 (2002) 143-148
72. Hirose H., Amano A., Takanashi S., and Takahashe A. Coronary artery bypass grafting using the gastroepiploic artery in 1,000 patients. Ann Thorac Surg 73 (2002) 1371-1379
73. Tavilla G., Kappetein A.P., Braun J., Gopie J., Tjien A.T.J., and Dion R.A.E. Long-term follow-up of coronary artery bypass grafting in three-vessel disease using exclusively pedicled bilateral internal thoracic and right gastroepiploic arteries. Ann Thorac Surg 77 (2004) 794-799
74. Nishida H., Tomizawa Y., Endo M., and Kurgosawa H. Survival benefit of exclusive use of in situ arterial conduits over combined use of arterial and vein grafts for multiple coronary artery bypass grafting. Circulation 112 Suppl I (2005) I-299-I-303